Log In
BCIQ
Print this Print this
 

TXA707

  Manage Alerts
Collapse Summary General Information
Company Taxis Pharmaceuticals Inc.
DescriptionSecond generation Staphylococcus aureus cell division protein FtsZ inhibitor
Molecular Target S. aureus cell division protein FtsZ
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsTreat Staphylococcus aureus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today